Skip to main content
. Author manuscript; available in PMC: 2022 Aug 23.
Published in final edited form as: Mol Imaging Biol. 2020 Sep 3;23(1):109–116. doi: 10.1007/s11307-020-01536-2

Table 3:

Pharmacokinetics of Panitumumab-IRDye800CW

Dose cohort Dose range (mg/kg) % of therapeutic dosea Total number of patients Half-life, average (h) (SD)
<0.5 mg/kg 0.06–0.49 1.0–8.2% 8 14.5 (4.12)
0.5–1.0 mg/kg 0.52–0.97 8.6–16.1% 32 20.9 (5.52)
1.0–1.5 mg/kg 1.05–1.48 17.5–24.7% 13 24.8 (6.9)
1.5–2.0 mg/kg 1.52–1.98 25.3–33.0% 10 35.7 (11.4)
2.0–3.0 mg/kg 2.09–2.84 34.8–47.3% 10 33.3 (5.4)
a

Therapeutic dose = 6 mg/kg.